PACTR202210523178727尚未招募3 期
Haem iron supplementation to combat iron deficiency and anaemia in African children
Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine0 个研究点目标入组 208 人开始时间: 2022年8月10日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 208
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 Month(s) 至 23 Month(s)（—）
- 性别
- All
入选标准
- •Children (male or female) at 6 to 12 months of age.
- •Anaemic children with Hb <11.0 g/dl and >7.0 g/dl.
- •Parent/guardian with participant reside in study area and are able and willing to adhere to all protocol visits and procedures (willingness to stay in the study area for the 12 weeks of supplementation).
- •Healthy with no current illness and no chronic health problems as assessed by nursing team.
- •Signed or fingerprinted informed consent obtained from participants parent/guardian.
排除标准
- •Children with history of low birthweight babies (ie less than 2.5kg at birth) or prematurity (ie born less than 37 weeks) will NOT be excluded unless extreme (<1500g or <34 weeks)
- •Formula fed infants or those whose mothers are planning to use commercially available infant formula as formula contains supplemental iron.
- •WHZ< -4 SD.
- •Recent hospitalization.
- •Not possible to collect venous blood samples at baseline.
- •Acute illness (once acute illness is resolved, if appropriate, as per nurse assessment, participant may be re-revaluated for eligibility).
- •Fever (for eligibility purpose defined as a body temperature greater than 37.5°C or mother report of fever) within 3 days prior to study initiation (once fever/acute illness is resolved, if appropriate, as per investigator assessment, participant may be re-revaluated for eligibility).
- •Administration of any investigational drug within 30 days prior to study initiation or planned administration during the study period.
- •Unwilling to avoid (to have their child avoid) the ingestion of other vitamin supplements or herbal/other traditional medications during the study period.
- •Any parentally reported history of chronic clinically significant disorder or disease (including, but not limited to, immunodeficiency, autoimmunity, congenital abnormality, bleeding disorder, and pulmonary, cardiovascular, metabolic, neurologic, renal, or hepatic disease).
- •Any parentally reported history of human immunodeficiency virus, chronic hepatitis B or chronic hepatitis C infections.
- •Any parentally reported history of sickle cell disease (HbSS), sickle cell anaemia, meningitis, seizures, Guillain-Barre´ syndrome, or other neurological disorders.
- •Any condition that in the opinion of the investigator or nursing team might compromise the safety or well-being of the participant or compromise adherence to protocol procedures.
研究者
相似试验
进行中（未招募）
1 期
Intravenous iron supplement for patients with severe aortic stenosis who have iron deficiencyIron deficiency, aortic stenosisMedDRA version: 20.0 Level: HLT Classification code 10022971 Term: Iron deficiencies System Organ Class: 100000004861EUCTR2019-002037-11-NOOslo University Hospital100
已完成
4 期
Iron Supplementation Prevent Iron Deficiency Anemia in Infants At Age 4 Months: A Randomized Controlled Trial; Pilot studyIron Supplementation can prevent iron deficiency anemia in Infants At Age 4 MonthsIron supplement, iron deficiency anemia, childrenTCTR20230112002Bhumibol Adulyadej Hospital20
进行中（未招募）
1 期
TREAT STUDY : TREATMENT OF IRON DEFICIENCY ANAEMIA WITH TARDYFERON. Importance of prolonging iron supplementation in anemic women of childbearing age - TREAT STUDYIron Deficiency Anaemia is a common pathology which concerns less than 5% of women aged 15 to 49 years old in the western countries but can affect up to 30% of the world population, knowing that 9 to 10 anaemic patients live in developing countries. Treating at least 3 months allows to normalize haemoglobin but it is important to carry on the iron treatment in order to fully replenish the iron stores.EUCTR2006-003378-90-FRPIERRE FABRE MEDICAMENT
已完成
2 期
Intake of Alternate Day Iron tablets in AnaemiaCTRI/2019/01/017169Dr Elamparithi Pasupathy200
进行中（未招募）
不适用
‘Intravenous iron treatment in iron deficient patients with pulmonary arterialhypertension' - Treating iron deficiency in PAHEUCTR2010-023233-30-NLVU university medical center30